Illumina Buys Epicentre Biotechnologies, Launches MiSeq Platform

The firm also plans to introduce upgrades for both its HiSeq 2000 and HiSeq 1000 platforms in the spring and expects reagent costs to drop to around $5,000 per genome.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.